Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
Immune Cell Therapies and Immune Cell Engineering
Immune Cell Therapies and Immune Cell Engineering
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
Troels Holz
Borch
,
Rikke
Andersen
,
Eva
Ellebaek
,
Özcan
Met
,
Marco
Donia
,
Inge
Marie Svane
Journal for ImmunoTherapy of Cancer
Jul 2020,
8
(2)
e000668;
DOI:
10.1136/jitc-2020-000668
Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells
Yuichi
Iida
,
Rintaro
Yoshikawa
,
Akihiko
Murata
,
Hitoshi
Kotani
,
Yasuhiro
Kazuki
,
Mitsuo
Oshimura
,
Yumi
Matsuzaki
,
Mamoru
Harada
Journal for ImmunoTherapy of Cancer
Jul 2020,
8
(2)
e000582;
DOI:
10.1136/jitc-2020-000582
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
Special collections
COVID-19
(45)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(560)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(983)
Commentary/Editorials
(153)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(56)
Guidelines and Consensus Statements
(53)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(242)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(437)
Liquid Biopsies
(10)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(151)
Reviews
(245)
The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)
(1)
Open access
(5026)
Press releases
(2)
